Profusa (PFSA) Net Equity Issued and Repurchased (2023)
Profusa (PFSA) posted quarterly Net Equity Issued and Repurchased of -$184.8 million for Q1 2023.
Profusa (PFSA) Net Equity Issued and Repurchased (2023) Analysis & Trends
Profusa's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at -$184.8 million for Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Profusa | 129,730.48 | -245,269.52 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -184.85 Mn |
| Mar 31, 2023 | -184.85 Mn |